Hu taishan,HAN XINGCHUN,KOU BUYU,SHEN HONG,YAN SHIXIANG,ZHANG ZHISEN
申请号：
IN201747024216
公开号：
IN201747024216A
申请日:
2017.07.10
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
14 The present invention relates to compounds of the formula (I) or pharmaceutically acceptable salts enantiomer or diastereomer thereof wherein R to Rare as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.
